Alethia Biotherapeutics to present at the AACR Annual Meeting 2014 at the San Diego Convention Center, San Diego, California. Drs. Mario Filion and Gilles Tremblay will present data on:
AB-3A4: A novel KAAG1-targeting antibody-drug conjugate is active in models of ovarian carcinoma, triple-negative breast cancer and castration-resistant prostate cancer. Abstract #666. Sunday, Apr 06, 2014, 1:00 PM – 5:00 PM; Hall A-E, Poster Section 28